The energy-dependent conversion of methionine to S-adenosyl-L-methionine (SAMe) is catalysed by S-adenosyl-L-methionine synthetase (SAMe-synthetase) in the liver. In the hepatocyte, an equilibrium exists between the high and low molecular weight forms of SAMe-synthetase. which consist of a tetramer and a dimer, respectively. of a 48.5 kilodalton subunit. The 2 enzymic forms differ in their affinity for methionine and sensitivity to inhibition by pyrophosphate; 2 of the sulfhydryl groups of SAMe-synthetase have been identified as essential for the normal functioning of the enzyme.
In patients with liver cirrhosis, a marked reduction in the utilisation of the high molecular weight SAMe-synthetase and displacement of the equilibrium occur, the molecular mechanism of which has yet to be established. This loss of activity is associated with a delay in methionine clearance and impairment of the trans-sulphuration pathway, which normally eliminates excess methionine by oxidising homocysteine to sulphate anion. It is hypothesised that in normal liver function the essential sulfhydryl groups of SAMe-synthetase are protected from oxidation by glutathione, a by-product of the transsulphuration pathway, However, glutathione levels are reduced in liver cirrhosis, and this may result in increased oxidation of the essential sulfhydryl groups. and consequent inactivation of the enzyme. Thus. the trans-sulphuration pathway may play an important role in the maintenance of normal SAMe-synthetase activity, Methionine, a sulphur-containing amino acid commonly found in proteins, was first isolated from milk casein in 1922.
Methionine is one of the so-called essential amino acids in mammals and the precursor of the synthesis of the amino acids homocysteine, cystine and cysteine, and of glutathione. In mammals, as much as 48% of methionine is metabolised by the liver (Zeisel & Poole 1978) , where most of it (about 80%) is converted into S-adenosy1-L-methionine (SAMe) [Mudd & Poole 1975] (fig. I ).
SAMe, like adenosine triphosphate (ATP), acts as a substrate in many biological reactions. Thus, after being decarboxylated, SAMe is the precursor in the synthesis of polyamines and is essential in transmethylation reactions (the process by which methyl groups are added to compounds).
A large variety of small molecules. phospholipids. nucleic acids and proteins are substrates of methylation reactions (Cantoni 1975) . which are also essential in many detoxification processes.
The first evidence of a methylation reaction was provided over 100 years ago when His described the conversion in the dog of pyridine to picoline. The product of all transmethylation reactions in which SAMe acts as a substrate is S-adenosyl-Lhomocysteine. which is subsequently converted into homocysteine and adenosine. Homocysteine can be either converted into cystine, cysteine and glutathione via the trans-sulphuration pathway. or used again for the synthesis of methionine ( fig. I ).
Structure and Function 0/ SAMe-Synthetase
The conversion of methionine to SAMe in the presence of ATP is catalysed by the enzyme S-adenosyl-L-methionine synthetase (also called SAMe-synthetase or methionine adenosyltransferase) [Cantoni 1975] . Two forms of SAMe-synthetase have been detected after rat or human liver cytosolic extracts were directly fractionated by gel filtration under conditions known to separate different SAMe-synthetase activities from this organ (Cabrero et al. 1987 ).These 2 enzymes, which have been purified to homogeneity, are termed high and low molecular weight (M r ) SAMe-synthetase and have an apparent M; of 210 and 110 kilodaltons (kD), respectively. as determined by gel filtration (Cabrero et al. 1987 . It has been shown, by tryptic peptide mapping and by immunoblotting using an antibody against the low M, enzyme, that both forms of SAMe-synthetase are constructed by the same polypeptide chain, which has an apparent M; of 48.5kD (Cabrero et al. 1987 ). The high M; form is a tetramer and the low M, form is a dimer of this subunit (Cabrero et al. 1987; Cabrero & Alemany 1988) . The 2 forms of SAMesynthetase differ in their regulatory and kinetic properties (Cabrero et al. 1987 ). Thus, although purified high M, SAMe-synthetase is inhibited in the presence of SAMe (100 to 300~moIjL) or pyrophosphate (0.5 to 1.0 mmol/L), at this concentration of SAMe and of pyrophosphate (also a product of SAMe synthesis) the low M, form is activated about lA-fold, and unaffected, respectively. Different kinetic values have been reported for methionine with the high M; and the low M; SAMe-synthetases (Cabrero et al. 1987; Okada et al. 1981; Sullivan & Hoffman 1983) . Kinetic studies carried out with the purified enzymes and using methionine in the range of I~mol/L to 10 mmol/ L indicate that both forms of the enzyme have nonlinear kinetics (Cabrero et al. 1987 ). The high M; SAMe-synthetase has a specific activity 15 times higher than that of the low M, SAMe-synthetase at methionine 60~moIjL (Cabrero et al. 1987 ), a concentration that is in the physiological range for this substrate (Finkelstein & Martin 1986) . At saturating concentrations of methionine, the maximal activity (Vmax) of the purified high M; and low M, enzymes is 35 nmol/min/rng and 24 nrnol/min/rng, respectively (Cabrero et al. 1987 ). In the presence of normal plasma levels of methionine, the tetramer is the most abundant form of the enzyme Matsumoto et al. 1984 ) and increases after a high dietary intake of methionine (Matsumoto et al. 1984) .
The high -M r and the low M; proportions of SAMe-synthetase change in the neonatal stage , in carcinogenesis ) and after the administration of galactosamine ) in rats. A marked reduction in total SAMe-synthetase has been demonstrated in cirrhosis (Gaul et al. 1970; MartinDuce et al. 1988) , when there is a reduced clearance of methionine (see below), and in adults with very high levels of plasma methionine (Gahl et al. Drugs 40 (Suppl. J) 1990 1988) . In cirrhosis, the reduction in total SAMe-synthetase is due to a specific loss of the high M, form of the enzyme .
Although the physiological purpose of these variations in the proportions of the high M, and low M; forms of the enzyme is not well understood, the present evidence suggests that it is probably a mechanism for controlling the hepatic synthesis of SAMe and maintaining normal plasma levels of methionine.
Interconversion Between the
High M, and the Low M, Forms 0/
SAMe-Synthetase
As previously mentioned, the proportions of the high M; and the low M; SAMe-synthetase are altered in the neonatal stage , in carcinogenesis , when the dietary uptake of methionine varies (Matsumoto et al. 1984) , and after galactosamine injection in rats. This argues against the possibility that these 2 forms of SAMe-synthetase are produced as artefacts during tissue hornogenisation. Moreover, the high M, form has been converted into the low M; form by incubation with 104 mol/L lithium bromide (Cabrera & Alemany 1988). The kinetic properties of the low M; enzyme obtained by lithium bromide treatment are the same as those obtained with the low M; SAMesynthetase purified from rat liver cytosol, indicating that the differences in specific activity and regulatory properties between the 2 forms of SAMesynthetase are due to different polymeric states. A catalytically active monomeric form of SAMesynthetase has been detected in the cytosolic extract from a liver biopsy ofa cirrhotic patient (Corrales et al. in press). These results exclude the possibility of a dimer in equilibrium with a catalytically inactive monomer and suggest a model in which the active monomer, after being formed, rapidly associates to form a dimer that is in equilibrium with the tetrameric form of the enzyme.
More recently, the possible role of sulfhydryl groups in maintaining the structure and activity of SAMe-synthetase was investigated by treating the purified enzyme with N-ethylmaleimide (Corrales et al. in press) . Both the high M; and the low M; forms of SAMe-synthetase are rapidly inactivated by N-ethylmaleimide, and the loss of enzyme activity correlates with the incorporation of approximately 2 moles of N-ethylmaleimide per enzyme subunit (presumably at 2 cysteine residues). It has been shown by use of tryptic peptide mapping that purified SAMe-synthetase contains 2 sites susceptible to modification with N-ethylmaleimide (Corrales et al. unpublished data). In addition, reaction with N-ethylmaleimide resulted in a displacement of the tetramer-dimer equilibrium of the enzyme towards the dimer, but no monomer was detected under these conditions. Escherichia coli SAMesynthetase is also a tetramer of identical subunits which, upon modification with N-ethylmaleimide of 2 cysteine residues per subunit, dissociates to form an inactive dimer (Markham & Satishchandran 1988) . These results suggest a high degree of conservation of SAMe-synthetase structure, from bacteria through to mammalian liver. Furthermore, present evidence identifies 2 sulfhydryl groups that are essential for maintaining SAMesynthetase structure and activity in the liver. Modification of sulfhydryl groups is a possible means of hepatocyte control of the equilibrium between both forms of the enzyme and may therefore be important in the adaptation to methionine excess. However, the molecular mechanism by which sulfhydryl modification might be responsible for the shift from the tetrameric to the dimeric form ofthe enzyme is not well understood. The subunits of certain enzymes dissociate upon treatment with sulfhydryl-combining reagents; hydrophobic binding as well as steric effects due to the introduced sulphur substituents have been suggested to explain this dissociation (reviewed by Jocelyn 1972) .
Impairment of SAMe Synthesis in Liver Cirrhosis
The response to a methionine load in normal subjects is an increase in the rate of SAMe synthesis [the methionine transamination pathway (Mitchell & Benevenga 1978) does not seem to be 61 able to maintain the levels of this amino acid within a normal range (Gahl et al. 1988 )], the excess SAMe being used to methylate glycine and form sarcosine, and to oxidise the methyl group of sarcosine. Simultaneously, the excess of S-adenosyl-L-homocysteine formed in this process is quantitatively metabolised to sulphate, with little conversion of homocysteine to methionine ( fig. I) [Mudd et al. 1980] . SAMe seems to play an important modulatory role in preventing the conversion of homocysteine to methionine. Thus, an elevation of the SAMe concentration reduces the synthesis of N5_ methyltetrahydrofolate, by inhibition of the enzyme methylenetetrahydrofolate reductase (Kutzbach & Stokstad 1967) , and increases the synthesis of cystathionine by stimulation of cystathionine i3-synthase (Finkelstein et al. 1975) . As a result of these modulatory effects of SAMe, the excess of homocysteine formed after a methionine load is directed to the production of sulphate and not to homocysteine methylation (Gahl et al. 1988 ). This metabolic sequence, however, is markedly altered in human liver cirrhosis. Thus, Kinsell et al. (1947) were first to observe a delay in the clearance of plasma methionine after its systemic administration to patients with liver damage and, more recently, Horowitz et al. (1981) reported a retardation of methionine clearance and a delay in sulphate excretion after an oral load of the amino acid in cirrhotics. These observations, together with the absence of accumulation of intermediates (homocysteine, homoserine and cystathionine) in plasma and urine (Horowitz et al. 1981) , suggested that the catabolism of methionine was inhibited above the level of the synthesis of homocysteine, probably at the level of the synthesis of SAMe. Gaull et al. (1970) reported that the activity of SAMe-synthetase was reduced by about 60% in 5 cirrhotic patients (3 with biliary cirrhosis, I with Wilson's disease and 1 in whom the cause of disease was unknown). Furthermore, Martin-Duce et al. (1988) have measured the activity ofSAMe-synthetase in liver biopsies from a group of 17 controls and from 26 patients with alcoholic or postviral cirrhosis. The activity of the enzyme was markedly reduced in the cirrhotic patients (285 ± 32 pmol/rnin/rng protein) when compared with that observed in controls (505 ± 37 pmol/rnin/rng protein). It is interesting that no differences in SAMesynthetase activity were observed between alcoholic and post-viral cirrhotic patients. The activity of the high M, form of SAMe-synthetase, but not of the low M; form, was found to be markedly reduced in liver biopsies from a group of 6 cirrhotics (73.9 prnol/min/rng protein) when compared with that of 6 controls (460.3 pmol/min/rng protein) . Thus, whereas the ratio of high M,: low M; in liver biopsies from control subjects is about 2.9, in cirrhotic subjects this ratio is 0.5 . The specific loss of the high M; tetramer appears to account for the higher levels of serum methionine found in these patients (231 ± 10 umol/L in control subjects compared with 354 ± 54 Ilmol/L in the cirrhotic patients) ]. This situation resembles that observed in rats treated with galactosamine, in which a 5-fold increase in the levels of serum methionine is accompanied by a 6-fold decrease in the ratio of high M r : low M, SAMe-synthetase activity ) and a 2-fold decrease in the levels of SAMe Stramentinoli et al. 1978) .
Despite this large reduction in SAMe-synthetase activity in liver cirrhosis, the concentration of this metabolite was the same in the control group (17.3 ± 2.6 Ilmol/L) as in the cirrhotic patients (17.8 ± 3.1 Ilmol/L). These results have been interpreted as being indicative of a reduced utilisation of SAMe in liver cirrhosis . A diminished utilisation of SAMe would cause a reduction in synthesis of S-adenosyl-L-homocysteine and, consequently, in sulphate excretion, which is consistent with the observations in cirrhotic subjects (Horowitz et al. 1981) . The finding that glutathione and cysteine levels are diminished in cirrhosis (Chawla et al. 1984) , as well as the observation that, in liver biopsies from cirrhotic subjects, there is a marked reduction in the synthesis of phosphatidylcholine by the transmethylation pathway (Martin-Duce et al. 1988) , favour the hypothesis of a reduced utilisation of SAMe in liver cirrhosis. In both rats and humans, the transmethylation path- way accounts for up to 40% of the total synthesis of phosphatidylcholine in the liver (Mato & Alemany 1983) . It would be interesting to know if other key enzymes of the methionine cycle, such as methylenetetrahydrofolic reductase and cystathionine ,,-synthetase, are also altered in liver cirrhosis.
Possible Causes of Impairment of SAMe Synthesis in Liver Cirrhosis
The mechanism by which SAMe-synthetase activity is diminished in cirrhosis has not been identified. As noted before, sulfhydryl groups are essential for maintaining SAMe-synthetase activity (Corrales et al. 1990 ). The functions of glutathione in the liver are the maintenance of a normal electrochemical potential, the scavenging of peroxides and free radicals, and the detoxification of drugs (Kaplowitz 1981) . Under normal liver conditions, oxidation of the sulfhydryl groups of SAMesynthetase may be protected by the cellular levels of glutathione. However, glutathione and cysteine levels are diminished in cirrhotic patients (Chawla et al. 1984 ) and in rats (Comporti et al. 1973; Feo et al. 1986 ) and humans (Videla et al. 1984) after the administration of ethanol. A reduction in liver glutathione may leave the sulfhydryl groups of SAMe-synthetase unprotected and therefore more susceptible to oxidation and may be the cause of the marked decrease in SAMe-synthetase activity observed in liver disease. As glutathione originates from SAMe through the trans-sulphuration pathway and, as it has been proposed (Corrales et al. 1990 ), may be an important factor in maintaining SAMe-synthetase activity and structure, impairment of the trans-sulphuration pathway at anyone level could gradually and progressively alter methionine metabolism ( fig. 2) . In this context, it is interesting to note that the administration of ethanol to rats causes a marked decrease in the liver content of both glutathione and SAMe (Feo et al. 1986 ). SAMe has been reported to restore glutathione levels in rats (Feo et al. 1986 ) and baboons (Lieber et al. 1990 ) treated with ethanol. Moreover, SAMe has been proven to increase hepatic gluta- thione levels in patients with alcoholic and nonalcoholic chronic liver disease (Vendemiale et al. 1989 ).
In conclusion, the causes of impairment of SAMe synthesis in human liver cirrhosis are currently not well understood. It is proposed (I) that the reduction in glutathione found in liver diseases may be responsible, at least in part, for the decreased SAMe~synthetase activity in these patients, and (2) that the administration of SAMe, through its conversion to glutathione. may restore SAMe synthetase activity to normal.
